Oliceridine Versus Sufentanil on Hypoxemia Incidence During Sedated Gastrointestinal Endoscopy
Status:
RECRUITING
Trial end date:
2025-10-26
Target enrollment:
Participant gender:
Summary
This study is a prospective, single-center, double-blind, randomized controlled trial designed to evaluate the effect of oliceridine versus sufentanil on the incidence of hypoxemia in adult patients undergoing gastrointestinal endoscopy under deep sedation. The trial will compare the rates of hypoxemia (defined as SpO 92%) between the two analgesic regimens when combined with propofol. The primary aim is to determine whether oliceridine can reduce the incidence of hypoxemia compared to sufentanil during endoscopic procedures.